All posts by Katie Reardon

Aptar Reports First Quarter 2020 Results; Continues to Provide Es...

Crystal Lake, Illinois, April 30, 2020 — AptarGroup, Inc. (NYSE:ATR) today reported first quarter results for 2020 and provided an update related to COVID-19 including the Company’s continued ability to supply essential solutions to critical industries.

First Quarter 2020 Summary

  • Reported sales decreased 3% and included negative effects from changes in currency exchange rates, passing on lower resin costs and COVID-19 impacts
  • Core sales, excluding currency and acquisition effects, decreased 2%
  • Core sales growth of 7% in our Pharma segment was offset by decreases in core sales in our other segments
  • A one-time cash Thank You Award was granted to employees who have made it possible for Aptar to continue to supply critical infrastructure industries during the COVID-19 crisis; $3.6 million of expense (pretax) is included in first quarter reported and adjusted earnings and a similar amount is expected to be recognized in the second quarter
  • Reported earnings per share totaled $0.84 (a decrease of 13%compared to the prior year)
  • Adjusted earnings per share totaled $0.93 (a decrease of 11% compared to the prior year)
  • Reported net income totaled $55 million (a decrease of 12% compared to the prior year)
  • Adjusted EBITDA totaled $144 million (a decrease of 7% compared to the prior year)
  • Cash flow from operations was $85 million (compared to $78 million in the prior year)
  • Free cash flow was $23 million (compared to $26 million in the prior year)
  • Declared quarterly dividend of $0.36 per share
  • Subsequent to the end of the quarter, completed the acquisition of FusionPKG
  • Undergoing daily monitoring of the COVID-19 pandemic and taking actions to maintain a continuity of supply while focusing on the health and safety of our people

Download the full press release.

April 30, 2020

COVID-19 Update for Our Customers and Partners

To Our Customers and Partners,

Aptar is committed to providing you with the best products and services, while also focusing on the health and safety of our people. We are closely monitoring the evolving coronavirus (COVID-19) situation and while the virus presents many challenges, we want you to know that we are taking steps to minimize risks to our people, our facilities and our partnership with you.

I would like to inform you of the measures Aptar is taking in regards to the evolving coronavirus pandemic in order to continue to support our customers to the best of our ability during this time:

  • We have implemented a Global COVID-19 Action Team who is meeting daily to identify and mitigate potential risks as much as possible. This Action Team has implemented a COVID-19 Exposure Control Plan, which was prepared by our Environment, Health and Safety team.
  • We are closely monitoring our entire supply chain up to the Tier-1 level, including direct materials, components and spare parts.
  • We are also taking steps to protect our production teams, so that we can continue our important work including manufacturing products that are very much needed to help fight the spreading of the virus, such as pumps and closures for sanitizing and antibacterial products, as well as the manufacturing of our pharma solutions that can help to save lives and our food and beverage solutions that are helping people with basic nutrition needs.
  • To protect our site production teams, we are restricting all visitors to only those essential for business continuity. We are restricting access to our canteens and cafeterias to our production teams only and encourage everyone to practice good hygiene and social distancing. We are also asking our cleaning service providers to escalate their cleaning and sanitizing procedures.
  • Currently, the local site HR departments, in combination with the site leadership teams, are preparing plans to have a proper balance of remote workers and on-site staff in order to support our customers and our ongoing production.

Should any risks arise which may affect your business, we will inform you and work to find alternative supply solutions.

At this time, and to the best of our knowledge, we have not identified any risks in the short-term with any of our Tier-1 partners. We are working to push our analysis further upstream and continue to monitor the evolution of the situation.

We are committed to taking all necessary measures to maintain the continuity of business and we will reach out to you should there be any known impact.

If you have any questions, please do not hesitate to contact your Aptar representative.

Sincerely,

Stephan B. Tanda

President and CEO, Aptar

Download the PDF

March 17, 2020

Aptar Reports 2019 Fourth Quarter and Annual Results

Aptar Reports Fourth Quarter and Annual Results; Recaps Year of Pharma Services Acquisitions and Multiple New Drug Delivery Launches; Highlights Strategic Steps to Strengthen Beauty Business

Crystal Lake, Illinois, February 20, 2020 — AptarGroup, Inc. (NYSE: ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions and services, today reported its fourth quarter and full year 2019 financial results.

Fourth Quarter 2019 Summary

  • Reported sales decreased 2% and were negatively affected by changes in currency exchange rates
  • Core sales, excluding currency and acquisition effects, declined 1% including a negative impact from passing on lower resin costs
  • Core sales growth in our Pharma segment was offset by decreases in core sales in our other segments
  • Reported earnings per share of $0.73 (up 18% compared to the prior year)
  • Adjusted earnings per share of $0.80 (down 13% compared to the prior year)
  • Reported net income of $49 million (up 19% compared to the prior year)
  • Adjusted EBITDA of $131 million (down 7% compared to the prior year)
  • Subsequent to the end of the quarter:
    • Completed the previously announced equity investment in BTY, a leading Chinese provider of decorative and complete color cosmetics packaging solutions
    • As previously announced, entered into a binding agreement to acquire FusionPKG, a design and rapid go-to-market specialist for the North American beauty market
    • Announced plans to consolidate North American Beauty + Home footprint

Annual 2019 Summary

  • Reported sales increased 3%
  • Core sales, excluding currency and acquisition effects, grew 3%
  • Reported earnings per share of $3.66 (up 22% compared to the prior year)
  • Adjusted earnings per share of $3.95 (up 2% compared to the prior year)
  • Reported net income of $242 million (up 24% compared to the prior year)
  • Adjusted EBITDA of $592 million (up 8% compared to the prior year)
  • Net cash provided by operations of $514 million
  • Free cash flow of $272 million
  • Raised cash dividend 6% and achieved our 26th consecutive year of paying increased dividends
  • Returned $177 million to shareholders for the year in dividends and share repurchases
  • Acquired strategic Pharma services (Nanopharm, Gateway Analytical, Noble International)
  • Made strategic investment in sustainable solutions partners PureCycle and Terracycle’s Loop
  • Named one of America’s Most Responsible Companies by Newsweek
  • Named one of America’s Most Sustainable Companies by Barron’s

Download the full press release

February 20, 2020

Aptar to Acquire FusionPKG, a Leader in Turnkey Solutions for the...

CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE:ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions, announced it has entered into a binding agreement to acquire Fusion Packaging I, L.P. (“FusionPKG”). FusionPKG is a leader in high quality, prestige airless and color cosmetics packaging, and conception-to-launch turnkey solutions for the North American beauty market.

FusionPKG, founded in 2004 by Jonathan Gross and Derek Harvey, has proven engineering, formulation and go-to-market capabilities for the North American fast beauty industry. FusionPKG has existing relationships with many global cosmetic and skin care customers as well as many rapidly growing indie brands. FusionPKG employs approximately 100 people across its headquarters in Dallas, sales and design offices in New York and Los Angeles, and operations in New Jersey and China. For 2019, FusionPKG generated sales of approximately $80 million. The transaction, which is expected to be accretive to Aptar’s Beauty + Home segment margins, is subject to customary closing conditions.

Stephan Tanda, Aptar President and CEO commented on the transaction, “We are very pleased to welcome the FusionPKG team to the Aptar family. This is a key step in our strategy to address market demands for fast beauty solutions with differentiated design and decorative offerings. We are strengthening our formidable portfolio by broadening our agile design and full-service beauty packaging capabilities. FusionPKG’s expertise in turnkey solutions is especially valuable to disruptive indie brands, as well as large established customers requiring expeditious launches. We believe the color cosmetics and skin care markets offer high growth potential, and FusionPKG has been growing at double-digit rates over the past few years. Our plan is to leverage FusionPKG’s market facing strengths in combination with our broad product and technology platforms. FusionPKG is an excellent complement to our current North American business, and there is great potential to scale this model in Europe and other regions.”

Derek Harvey, FusionPKG Co-Founder, stated, “This is the next step in our entrepreneurial growth journey and Aptar is the perfect fit for us. We see tremendous commercial synergies and are very excited about combining our core design and concept-to-launch expertise with Aptar’s global network and broad product portfolio.”

Added FusionPKG Co-Founder, Jonathan Gross, “Our culture is based on innovation, speed to market and flawless execution. Having Aptar’s resources will bolster our products and services, meeting the high demands of fast beauty.”

Wells Fargo Securities acted as the exclusive financial advisor to Aptar in connection with the transaction and Sidley Austin LLP acted as legal counsel.

Upcoming Open Conference Call

Aptar will offer further comments and answer questions about the FusionPKG acquisition during its planned conference call on Friday, February 21, 2020 at 8:00 a.m. Central Time when the Company will discuss fourth quarter and year-end results for 2019. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investor Relations page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investor Relations page of the website.

Download the full press release.

February 14, 2020

Aptar Declares Quarterly Dividend

Crystal Lake, Illinois, January 16, 2020 – AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, today declared a quarterly cash dividend of $0.36 per share. The payment date is February 19, 2020, to stockholders of record as of January 29, 2020.

As previously announced, Aptar will hold a conference call on Friday, February 21, 2020 at 8:00 a.m. Central Time to discuss the Company’s fourth quarter and year-end results for 2019. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investor Relations page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investor Relations page of the website.

Download the full press release.

January 16, 2020

Aptar Announces Quarterly Conference Call and Annual Meeting Info...

Crystal Lake, Illinois, January 2, 2020 – AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases.

Quarterly Conference Calls

Press Release (1) Conference Call (2)
4th Quarter and Annual 2019 Results February 20, 2020 February 21, 2020, at 8:00 a.m. CT
1st Quarter 2020 Results April 30, 2020 May 1, 2020, at
8:00 a.m. CT
2nd Quarter 2020 Results July 30, 2020 July 31, 2020, at
8:00 a.m. CT
3rd Quarter 2020 Results October 29, 2020 October 30, 2020, at 8:00 a.m. CT

(1) Press releases will be issued on the dates noted after the close of trading on the New York Stock Exchange.

(2) Times shown are in the Central U.S. time zone. Conference calls will last approximately one hour and interested parties are invited to listen to a live webcast by visiting the Investor Relations page of the Aptar website at www.aptar.com. Replay of the conference calls can also be accessed on the Investor Relations page of the website.

Annual Meeting

The Board also announced that the 2020 Annual Meeting of Stockholders will be held at Aptar’s corporate headquarters, 265 Exchange Drive, Suite 100, Crystal Lake, Illinois, on May 6, 2020, at 9:00 a.m. CT. The record date for stockholders entitled to vote at the meeting is March 13, 2020.

Download the full press release.

January 2, 2020

Aptar’s Nasal Unidose Device Approved by U.S. FDA for First Nas...

Crystal Lake, Illinois, December 9, 2019 – AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, today announced that its patented Unidose Liquid System is the device delivering the first and only nasal rescue treatment approved by the U.S. FDA, which has recently launched in the U.S. to treat acute repetitive seizures in people living with epilepsy. This ready-to-use rescue treatment can be used when and where a seizure cluster occurs thanks to Aptar’s proven, intuitive and convenient Unidose Liquid System.

Noble International, recently acquired by Aptar and part of Aptar Pharma’s services offering, developed a trainer device in partnership with the customer to be used as part of a patient onboarding program for this new drug product.

Stephan Tanda, Aptar President and CEO, stated, “This approval and successful market launch further demonstrate the broad potential for Aptar’s patient-friendly drug delivery solutions and service offerings which help our pharmaceutical customers address unmet healthcare needs. We are pleased to offer a broad portfolio of innovative technologies and wide array of services to meet the highest quality standards of the pharmaceutical industry.”

Solution for Nasally Administered Treatments

Aptar’s Unidose Liquid System is a single-use, ready-to-use one-step nasal delivery device which can deliver a formulation in an emergency situation quickly and easily and can be administered by a non-healthcare professional to a patient during or after a seizure. During such an event, the patient or caregiver presses a small plunger on the bottom of the device to release the drug in a single spray into the nostril, where the drug can be quickly absorbed via the nasal mucosa.

Patented Unidose and Bidose Technology Platforms

Aptar’s Unidose and Bidose platforms are robust, primeless, and intuitive systems with 360° functionality and precise nasal drug delivery. They offer biotech and pharmaceutical companies effective and reliable single or two-shot intranasal delivery for a variety of medicines including potential life-saving drugs and treatments of severe conditions. The devices can also integrate wireless connectivity technologies.

Accelerated Development Support and Training via Aptar Pharma Services

This innovative rescue treatment for seizure activity is an example of a Combination Product submission, and benefited from Aptar Pharma’s services offering, a comprehensive portfolio of stage-specific development packages. Aptar’s dedicated Regulatory Affairs experts and analytical scientists help customers proactively address regulatory needs to accelerate approval.

“The launch of our Unidose System on the first and only U.S. FDA approved nasal rescue treatment for seizure activity once again demonstrates Aptar Pharma’s ability to help our customers develop and launch complex treatments,” stated Gael Touya, President, Aptar Pharma. “When we combine our nasal systems’ capabilities with Noble’s training devices for onboarding, we bring added value to our customers and further convenience for patients and consumers worldwide.”

Download the full press release.

December 9, 2019

Aptar Reports Third Quarter Results; Acquires Noble International...

Crystal Lake, Illinois, October 31, 2019 — AptarGroup, Inc. (NYSE:ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions, today reported its third quarter 2019 financial results. In addition, Aptar has acquired Noble International (Noble), a leader in drug delivery training devices and patient onboarding and announced certain segment leadership appointments.

Third Quarter 2019 Summary

  • Reported sales increased 5%
  • Core sales, excluding currency and acquisition effects, grew 4%
  • Reported earnings per share increased 42% to $0.85 compared to prior year earnings per share of $0.60 in part due to lower restructuring and acquisition costs
  • Adjusted earnings per share decreased 4% to $0.93 compared to prior year adjusted earnings per share of $0.97 (including comparable exchange rates), primarily due to a difference in the effective tax rate on adjusted earnings (31% vs 24%, or approximately $0.09 per share)
  • Reported net income increased 46%
  • Adjusted EBITDA increased 9%, despite foreign currency headwinds
  • Subsequent to the end of the quarter, acquired Noble, a leader in drug delivery training devices and patient onboarding

Download the full press release.

 

 

October 31, 2019

Aptar Declares Quarterly Dividend

Crystal Lake, Illinois, October 17, 2019 — The Board of Directors of AptarGroup, Inc. (NYSE: ATR) today declared a quarterly cash dividend of $0.36 per share. The payment date is November 20, 2019, to stockholders of record as of October 30, 2019.

As previously announced, Aptar will hold a conference call on Friday, November 1, 2019 at 8:00 a.m. Central Time to discuss the Company’s third quarter results for 2019. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investor Relations page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investor Relations page of the website.

Download the full press release.

October 17, 2019

Aptar to Acquire a Strategic Equity Interest in BTY, a Leading Ch...

Crystal Lake, Illinois, October 7, 2019 – AptarGroup, Inc. (NYSE: ATR), a global leader in dispensing, drug delivery and active packaging solutions, announced today that it has signed an agreement to acquire a 49% equity interest in three related BTY companies: Suzhou Hsing Kwang (“SZHK”), Suqian Hsing Kwang (“SQHK”) and Suzhou BTY (“BTY”), collectively referred to as BTY. The BTY entities are leading Chinese manufacturers of high quality, decorative metal components, metal-plastic sub-assemblies, and complete color cosmetics packaging solutions for the beauty industry.

This strategic investment brings complementary and distinctive capabilities to Aptar including high speed stamping and anodization, metal and plastic decoration and differentiated lipstick masstige mechanism design and manufacturing. This investment positions Aptar well to capitalize on growth potential in the Asian color cosmetics market, while further strengthening Aptar’s ability to serve customers focused on the color cosmetics markets.

Commenting on the transaction, Stephan Tanda, Aptar President and CEO, said, “We are committed to growing our business in Asia and to creating an even stronger local presence in this region. This strategic equity investment better positions us in the high-growth Asian color cosmetics market and we look forward to leveraging our expansive portfolio of dispensing technologies, along with our global scale, to build upon BTY’s success in this market. This transaction meets our disciplined investment approach of acquiring leading, recognized players with innovative technologies and know-how, and includes an option to raise our stake in future years. We look forward to welcoming BTY to the Aptar family.”

Financial details will be disclosed upon successful completion of the transaction. The transaction is subject to customary regulatory approvals and is expected to close by the end of 2019 and the purchase will be funded with available cash on hand.

Since founding the business in 2002, Mr. Liang Cheng has developed a business with deep management expertise responsible for developing packaging that is used by both local Chinese and multinational color cosmetics brands. The three facilities employ 900 people and are located close to Aptar’s manufacturing facilities in the Suzhou, Jiangsu Province in China and offer proximity to leading cosmetics manufacturing players that serve the local, regional and global markets.

“Aptar and BTY share many of the same values including the desire to improve the lives of consumers around the world,” explained Liang Cheng, Founder of the BTY companies. “Aptar, a leader in the beauty, pharmaceutical and food packaging industries, continuously strives to provide customers with the perfect innovative solution. This drive is also found in BTY’s DNA. Together, we will be able to provide customers with further agility, speed to market and an enhanced portfolio of products and services, all while contributing positively to people’s lives, our society and ultimately the planet.”

Xiangwei Gong, President of Aptar Asia, stated, “We have a strong focus to grow in Asia through strategic partnerships as well as acquisitions. This strategic equity interest in BTY is key to our strategy as it allows us to create even stronger local teams, co-create local innovations and leverage the strength of Aptar’s global capabilities for our Asian customers in the color cosmetics market.”

Download the full press release.

October 7, 2019

Aptar Reports Second Quarter Results

Crystal Lake, Illinois, July 31, 2019 — AptarGroup, Inc. (NYSE:ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions, today reported second quarter 2019 financial results.

Second Quarter 2019 Summary

  • Reported sales increased 5%
  • Core sales, excluding currency and acquisition effects, grew 4%
  • Reported earnings per share increased 30% to $1.12 compared to prior year earnings per share of $0.86
  • Adjusted earnings per share increased 10% to $1.15 compared to prior year adjusted earnings per share of $1.05 (including comparable exchange rates)
  • Reported net income increased 33%
  • Adjusted EBITDA increased 14%, despite foreign currency headwinds
  • Expanded portfolio of services that support pharmaceutical and biotech customers with acquisitions of Nanopharm and Gateway Analytical

Download the full press release.

July 31, 2019

Aptar Declares Quarterly Dividend

Crystal Lake, Illinois, July 17, 2019 — The Board of Directors of AptarGroup, Inc. (NYSE: ATR) today declared a quarterly cash dividend of $0.36 per share. The payment date is August 21, 2019, to stockholders of record as of July 31, 2019.

As previously announced, Aptar will hold a conference call on Thursday, August 1, 2019 at 8:00 a.m. Central Time to discuss the Company’s second quarter results for 2019. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investor Relations page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investor Relations page of the website.

July 17, 2019

Aptar Acquires Nanopharm and Gateway Analytical, Broadening Pharm...

Crystal Lake, Illinois, June 10, 2019 – AptarGroup, Inc. today announced that it has acquired two leading pharmaceutical services companies, Nanopharm Ltd. and Gateway Analytical LLC, for a combined enterprise value of approximately $50 million. The acquisitions are part of Aptar’s strategy to broaden its portfolio of services that support pharmaceutical and biotech customers to accelerate and derisk their complex product developments.

Both acquisitions bring complementary, value-added and differentiated analytical, testing and development services for all stages of drug development and commercialization. The expanded services platform will enable Aptar Pharma to collaborate earlier with customers to support their complex drug formulations and delivery requirements as they face increasingly competitive and regulated markets.

Nanopharm, located in Newport, UK, is a science-driven, leading provider of orally inhaled and nasal drug product design and development services. Gateway Analytical, located in Gibsonia, PA, provides industry-leading particulate detection and predictive analytical services to customers developing injectable medicines. The companies’ results will be included in the Pharma segment and the transactions are not expected to be dilutive to Aptar’s earnings in 2019.

“We are delighted to welcome the talented teams of Nanopharm and Gateway and their customers to Aptar Pharma,” commented Gael Touya, President of Aptar Pharma. “Their expertise and capabilities will deepen our current range of services offered to customers who are developing and testing inhaled and injected medicines. This enables us to participate in a broader spectrum of the pre-clinical, clinical trial and market launch phases of drug development.”

Stephan Tanda, President and CEO, stated, “These strategic investments further strengthen our best in class Pharma business and increase our ability to add to our long-term growth pipeline by adding depth to our service offerings. The expertise of two established leaders, Nanopharm, a leader in inhalation and nasal drug development services, and Gateway, a leader in particulate detection and analysis for the injectables market, are complementary to our existing laboratory and analytical services and will bring additional value to our customers as they navigate the challenging regulatory landscape and seek to bring their products to market faster.”

Download the full press release.

June 10, 2019

Aptar Announces the Appointment of Isabel Marey-Semper to the Boa...

Crystal Lake, Illinois, May 1, 2019 — AptarGroup, Inc. (NYSE:ATR), announced today that Isabel Marey-Semper has joined Aptar’s Board of Directors.

Isabel is a trained scientist and experienced transformation leader who was most recently the Executive Vice President, Communications and Public Affairs and General Manager for L’Oréal. Prior to that, Isabel was the Chief Financial Officer of Groupe PSA (Peugeot Citroën) and has also held a senior executive roles at the multinational company, Saint-Gobain. She also served on the board of Nokia for several years.

Stephan Tanda, Aptar President and CEO, stated, “We are thrilled to welcome Isabel Marey-Semper to our Board. As a trained scientist and experienced transformation leader, Isabel brings tremendous breadth and depth of experience. She has deep insights into the French business culture and, at the same time, a strong grasp of global business imperatives. She will be a great addition to our Board.”

Commenting on Aptar’s Board membership, George Fotiades, Chairman of the Board, explained, “We have an exceptionally strong, truly international and diverse Board of Directors at Aptar. Our directors are highly experienced, reflective of, and deeply knowledgeable about, the markets we serve and the strategies we pursue. With 40% of our Board consisting of female directors, we are proud to be among the companies leading the way towards gender balance on corporate boards.”

Isabel holds a Master of Science degree, an MBA and a PhD degree in Neuro-Pharmacology. Isabel is also a Director for Damae Medical, a medical company focused on diagnosing skin tumors without the need for a biopsy; Imagine Institute, a medical research organization focused on the treatment of genetic diseases; and the Inria Foundation, a research organization dedicated to digital science and technology.

Download the full press release.

May 1, 2019

Aptar Reports First Quarter Results

Crystal Lake, Illinois, April 30, 2019 — AptarGroup, Inc. (NYSE:ATR) today reported first quarter results for 2019.

First Quarter 2019 Summary

  • Reported sales increased 6%
  • Core sales, excluding currency and acquisition effects, grew 7%
  • Reported earnings per share increased 4% to $0.96 compared to prior year earnings per share of $0.92
  • Adjusted earnings per share increased 16% to $1.07 compared to prior year adjusted earnings per share of $0.92 (including comparable exchange rates)
  • Reported net income increased 6%
  • Adjusted EBITDA increased 15%, despite foreign currency headwinds
  • Increased quarterly dividend 6% to $0.36 per share; 2019 will be our 26th consecutive year of paying increased annual dividends

Download the full press release.

April 30, 2019

Aptar Announces New $350 Million Share Repurchase Authorization a...

Crystal Lake, Illinois, April 18, 2019 — The Board of Directors of AptarGroup, Inc. (NYSE: ATR) yesterday authorized the repurchase of up to $350 million of the Company’s common stock. This new authorization replaces all previous authorizations. Aptar may repurchase shares through the open market, privately negotiated transactions or other programs, subject to market conditions. The Board also increased the quarterly cash dividend by 6% to $0.36 per share. The payment date is May 22, 2019, to stockholders of record as of May 1, 2019.

Stephan Tanda, President and CEO, commented, “The new share repurchase authorization and increased dividend reflect our strong balance sheet and the confidence we have in the long-term growth prospects for the company. We are providing shareholders with current returns while we continue to invest in the business and remain flexible to take advantage of strategic acquisition opportunities. This will be our 26th consecutive year of paying an increased dividend.”

As previously announced, Aptar will hold a conference call on Wednesday, May 1, 2019 at 8:00 a.m. Central Time to discuss the Company’s first quarter results for 2019. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investor Relations page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investor Relations page of the website.

Download the full press release.

April 18, 2019

Aptar Wins sHero Award for Best Company for Female Executives

The 2019 Global Woman & Future Conference organized by sHero was held at the Portman Ritz Carlton, Shanghai, China on March 29, 2019. sHero is a non-profit organization focused on empowering women through employment, education and engagement. The conference aims to respond to the International Women’s Day theme – Balance for Better: Creating Inclusive Growth and Sustainable Prosperity.

Aptar won the silver award for “Best Company for Female Executives”, among many well-known companies. Becton Dickinson (BD) also won a silver award and the gold award went to Honeywell. The awards celebrate the exceptional companies in the China region that are committed to moving women to the top. The awards also recognize the outstanding companies dedicated to creating an inclusive culture that identifies, promotes and supports women reaching their career goals.

Dr. Andy Zou, President, Aptar Greater China, accepting the award on behalf of Aptar said, “I am happy to work with a great and diverse leadership team and I expect more men to engage in these activities. Let’s all contribute to create inclusive growth and sustainable prosperity together.”

The founder of sHero, Christine Liu said, “The most inspiring thing about Aptar is that they support women’s leadership acceleration from top to bottom, from their global CEO, Asia President, and Greater China President, to their employees. They all demonstrated consistent commitment to women’s advancement in the workplace. What is more impressive is that the local leadership team participated this conference for the full day program. They actively interacted with speakers and delegates from other organizations and companies.”

She also explained, “When we see more and more people around the world mobilizing for a more equal future, it clearly shows that we need women leaders more than ever before. When women use their power and connections to achieve their goals, they are unstoppable. Women and girls are innovating and working together to design a better future for everyone. We are not going back. We have to build for a more equal future.”

Nearly 50 well-known entrepreneurs, celebrities and industries from all walks of life were invited as speakers. They discussed and reflected on the importance role of women in participating in company development and social economic development with more than 200 delegates from renowned enterprises such as Jala, Mary Kay, BD, GSK, Pfizer, and Honeywell. Aptar’s Asia President, Ms. Xiangwei Gong, was also invited to be one of panelists to share her opinions on growth through diversity.

Diversity and Inclusion is one of the most important strategic priorities at Aptar. Today, Aptar’s Board of Directors consists of eleven members, three of whom are women. The Board has three functional committees, the Governance committee, the Management Development and Compensation Committee and the Audit Committee, and Aptar’s women directors are the chairpersons of each committee. In Aptar’s China management team, women leaders account for 50%. Aptar strongly supports employee development, advocates gender equality, and creates an inclusive culture that identifies, promotes and supports women reaching to the top. Aptar is extremely proud of its diverse, global, highly skilled workforce and of all of the accomplishments achieved together. The company looks forward to making continued progress in the area of diversity and inclusion as it looks to the future.

Linda Lian, an Aptar employee and volunteer for the conference, said, “I have learned a lot from these speakers which will have huge influence on my future career and life. Personally, I am very passionate about women’s leadership acceleration. I am very happy that I joined Aptar, a company really cares about women’s leadership and I can feel it every day at work. I’m so proud of my company.”

Top photo: Aptar’s team from Asia attends the 2019 Global Woman & Future Conference organized by sHero. From left to right: Season Zhang, Kelsey Qiang, Selina Lin, Grace Ding, Peter Zhu, Weida Zhang, Andy Zou, Xiangwei Gong, Helen Zhu, Tina Xu, Susan Gu, Linda Lian, Jenny Cao

Dr. Andy Zou, President, Aptar Greater China (center), accepts the silver award for “Best Company for Female Executives”

Ms. Xiangwei Gong, President of Aptar Asia, participates in a panel discussion regarding growth through diversity

April 10, 2019

Aptar Reports Fourth Quarter and Annual Results

Crystal Lake, Illinois, February 20, 2019 — AptarGroup, Inc. (NYSE:ATR) today reported fourth quarter and annual results for 2018.

Fourth Quarter 2018 Summary

  • Reported sales increased 9%
  • Core sales, excluding currency and acquisition effects, grew 7%
  • Reported earnings per share decreased 19% to $0.62 compared to prior year earnings per share of $0.77
  • Adjusted earnings per share increased 19% to $0.92 compared to prior year adjusted earnings per share of $0.77 (including comparable exchange rates)
  • Reported net income decreased 18%
  • Adjusted EBITDA increased 20%
  • Pharma segment earnings included a positive impact of approximately $6 million related to a gain on the sale of an equity investment
  • Food + Beverage segment earnings included a negative impact of approximately $2 million related to the write-off of a prepaid license fee

Annual 2018 Summary

  • Reported sales increased 12%
  • Core sales, excluding currency and acquisition effects, grew 8%
  • Reported earnings per share decreased 12% to $3.00 compared to prior year earnings per share of $3.41
  • Adjusted earnings per share increased 13% to $4.00 compared to prior year adjusted earnings per share of $3.54 (including comparable exchange rates)
  • Reported net income decreased 11% and reported net income margin (% of net sales) was 7% compared to 9% a year ago
  • Adjusted EBITDA increased 16% and adjusted EBITDA margin was 20% compared to 19% a year ago
  • Acquired strategic technologies (CSP Technologies and Reboul)
  • 2018 was our 25th consecutive year of paying an increased dividend

Download the full press release.

February 20, 2019

Aptar Named One of the Top 100 Most Sustainable U.S. Companies by...

Aptar has been named one of the Top 100 Most Sustainable U.S. Companies by Barron’s as part of their 2019 ranking. Aptar was ranked number 79 on the top 100 list. Calvert Research and Management compiled Barron’s list, and evaluated the 1,000 largest publicly held U.S. companies (by stock market value). The rankings were then based on hundreds of metrics addressing environmental, social, and corporate governance, or ESG, factors.

To read more about Aptar’s sustainability efforts, please view our Corporate Sustainability Report.

February 11, 2019

Aptar Joins the World Business Council for Sustainable Developmen...

Crystal Lake, Illinois, February 5, 2019 — AptarGroup, Inc. (NYSE: ATR) announced today that it has joined nearly 200 forward-thinking companies as the newest member of the World Business Council for Sustainable Development (WBCSD).

As global businesses face new, complex challenges and opportunities, WBCSD’s science-based approach and targeted business solutions aim to scale up business impact to the most challenging sustainability issues. WBCSD targets the realization of Sustainable Development Goals through six work programs – Circular Economy, Cities and Mobility, Climate and Energy, Food, Land and Water, People and Redefining Value – to achieve systems transformation.

Stephan Tanda, Aptar President and Chief Executive Officer said, “We are delighted to join WBCSD and the other member companies who are part of this critical commitment to accelerating the transition to a sustainable world. As a global company, we are committed to reducing our impact on the planet while creating top quality, sustainable products. Connecting with WBCSD’s 200 members provides an invaluable opportunity to share best practices and work on larger projects with aligned objectives. We are particularly interested in WBCSD’s innovative work in relation to the circular economy, including the Global Plastics Alliance, along with its focus on climate, energy and the Sustainable Development Goals.”

WBCSD President and CEO Peter Bakker said, “WBCSD is pleased to welcome Aptar as our newest member. We are dedicated to working towards a transformation of the key systems across society, and this can only be achieved in collaboration with companies across the full value chain. Aptar has touchpoints across many products and services that help to improve the lives of millions of people around the globe, along with a commitment to ensuring these offerings are sustainable for both people and the planet.”

In addition to leading in corporate sustainability, Aptar is committed to seeking opportunities to replace fossil-based resins, to increase its offering of sustainable dispensing solutions and to collaborate with its customers on re-fillable products. The company’s Product Sustainability Team is addressing customer, consumer and regulatory expectations for sustainable product offerings. To date, Aptar has launched closures in North America and Europe made with post-consumer recycled resins (PCR) and continues to explore additional opportunities for sustainable resins and fully recyclable products. Furthermore, Aptar’s existing technologies, including multi-use, re-sealable dispensing closures, and spray and lotion pumps, are well suited to address the evolving need to re-use and re-fill.

Download the full press release.

February 5, 2019